Latest News
Jiangsu Provincial Institute of Materia Medica Selects Provantis Preclinical SaaS Solution
Provantis to Increase Efficiencies and Further Improve Study Data Quality at Nanjing Research Facility
CONSHOHOCKEN, PA – Business Wire, June 4, 2019 - - Instem, a leading provider of IT solutions to the global life sciences market, announced today that Jiangsu Provincial Institute of Materia Medica (JPIMM), has purchased the Provantis® preclinical SaaS solution suite to manage preclinical processes at its research facility in Nanjing.
FDA SEND 3.1 Mandate Goes Into Effect
March 15, 2019 - Scope of SEND Widens to Include Support for Cardiovascular and Respiratory Studies
Instem to Showcase Deep RIM Capabilities at DIA’s Upcoming RSIDM Exhibition
February 7, 2019 - Instem to Present Single-Place-of-Truth™ Approach for Regulatory Affairs Professionals
Instem’s Genetox Software Solution Complements Litron’s State-of-the-Art Genetic Toxicology Testing Methods
February 05, 2019 - Instem Reports that Leading R&D Organizations are Deploying Cyto Study Manager & Cutting-Edge Flow-Cytometric Regulatory Genetox Testing Techniques
Instem Reports Strong Demand for SEND Data Visualization Software in Preclinical Market
January 29, 2019 - Instem is pleased to announce increased demand for its SEND Explorer® software solution.
MedTech Summit 2019
June 17 - 21, 2019
Crowne Plaza, Brussels, Booth #21
Proud sponsors of the IGG 33rd Annual Meeting
June 19 - 20, 2019
Manchester, UK
Annual Meeting of the Chinese Society of Toxicology
June 22 - 24, 2019
Wuhan, Hubei Province